Showing results (1611-1620 of 3,660) with videos related to
Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|June 3, 2020
Clinical utility of tumour marker velocity of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillanceJ X Hing, C W Mok, P T Tan, et al.Breast (Edinburgh, Scotland)|June 8, 2020
The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trialLeonard R, Yellowlees A, Mansi J, et al.Breast (Edinburgh, Scotland)|May 26, 2020
A multi-stakeholder approach in optimising patients' needs in the benefit assessment process of new metastatic breast cancer treatmentsFatima Cardoso, Nils Wilking, Renato Bernardini, et al.Breast (Edinburgh, Scotland)|February 5, 2023
Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancerCvetka Grašič Kuhar, Simona Borštnar, Barbara Gazić, et al.Breast (Edinburgh, Scotland)|January 30, 2023
Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment targetFrançois Richard, Maxim De Schepper, Marion Maetens, et al.Breast (Edinburgh, Scotland)|January 26, 2023
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancerArlene Chan, Manuel Ruiz-Borrego, Gavin Marx, et al.Breast (Edinburgh, Scotland)|February 24, 2023
Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trialMira Goldberg, Sameer Parpia, Eileen Rakovitch, et al.Breast (Edinburgh, Scotland)|November 14, 2022
Real-world data of HER2-low metastatic breast cancer: A population based cohort studyEmily I Holthuis, Gerard T Vondeling, Josephina G Kuiper, et al.Breast (Edinburgh, Scotland)|November 14, 2022
Patterns of care over 10 years in young breast cancer patients in the Netherlands, a nationwide population-based studyNansi Maliko, Nina Bijker, Monique Emm Bos, et al.Breast (Edinburgh, Scotland)|November 21, 2025
Health-related quality of life and fear of recurrence after early breast cancer treatment: Results from a cross-sectional surveyPaola Mosconi, Secondo Folli, Rosalba Miceli, et al.Pageof 366